Medicalgorithmics S.A. (WSE:MDG)
Poland
· Delayed Price · Currency is PLN 25.95
+0.20 (0.78%)
Jun 5, 2025, 1:44 PM CET
Medicalgorithmics Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 23.75 | 24 | 43.1 | 62.72 | 48.35 | 111.73 | Upgrade
|
| Revenue Growth (YoY) | -38.82% | -44.31% | -31.28% | 29.72% | -56.73% | -35.74% | Upgrade
|
| Cost of Revenue | 21.06 | 21.86 | 26.15 | 29.52 | 22.84 | 100.44 | Upgrade
|
| Gross Profit | 2.69 | 2.14 | 16.95 | 33.2 | 25.51 | 11.29 | Upgrade
|
| Selling, General & Admin | 15.46 | 15.67 | 13.36 | 12.22 | 8.7 | 29.88 | Upgrade
|
| Other Operating Expenses | -0.49 | -0.63 | 1.51 | 1.01 | 0.53 | 3.98 | Upgrade
|
| Operating Expenses | 18.69 | 18.68 | 17.23 | 17.24 | 13.41 | 49.75 | Upgrade
|
| Operating Income | -16 | -16.54 | -0.28 | 15.96 | 12.1 | -38.46 | Upgrade
|
| Interest Expense | -0.55 | -0.16 | -0.11 | -0.27 | -0.61 | -0.96 | Upgrade
|
| Interest & Investment Income | - | - | 0.75 | - | 0.24 | 0.18 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -1.35 | 8.08 | 2.9 | -1.6 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.6 | 0.92 | 0.04 | 0.24 | 0.11 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | -15.95 | -15.78 | -0.95 | 24.01 | 14.73 | -40.9 | Upgrade
|
| Asset Writedown | - | - | 0.71 | - | -21.74 | -3.11 | Upgrade
|
| Other Unusual Items | - | - | - | 1.26 | - | 4.06 | Upgrade
|
| Pretax Income | -15.95 | -15.78 | -0.24 | 25.26 | -7.01 | -39.95 | Upgrade
|
| Income Tax Expense | 0.32 | 0.3 | 0.34 | -0.22 | -0.44 | -12.27 | Upgrade
|
| Earnings From Continuing Operations | -16.27 | -16.08 | -0.58 | 25.48 | -6.57 | -27.68 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -37.34 | -174.07 | - | Upgrade
|
| Net Income to Company | -16.27 | -16.08 | -0.58 | -11.86 | -180.64 | -27.68 | Upgrade
|
| Minority Interest in Earnings | -0 | - | - | - | - | 14.76 | Upgrade
|
| Net Income | -16.27 | -16.08 | -0.58 | -11.86 | -180.64 | -12.92 | Upgrade
|
| Net Income to Common | -16.27 | -16.08 | -0.58 | -11.86 | -180.64 | -12.92 | Upgrade
|
| Shares Outstanding (Basic) | - | 10 | 10 | 6 | 5 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | - | 10 | 10 | 6 | 5 | 4 | Upgrade
|
| Shares Change (YoY) | - | -0.27% | 74.58% | 25.38% | 9.88% | 14.72% | Upgrade
|
| EPS (Basic) | - | -1.62 | -0.06 | -2.08 | -39.73 | -3.12 | Upgrade
|
| EPS (Diluted) | - | -1.62 | -0.06 | -2.08 | -39.73 | -3.12 | Upgrade
|
| Free Cash Flow | -8.14 | -13.22 | -0.31 | 6.33 | -16.39 | -4.37 | Upgrade
|
| Free Cash Flow Per Share | - | -1.33 | -0.03 | 1.11 | -3.60 | -1.06 | Upgrade
|
| Gross Margin | 11.33% | 8.93% | 39.34% | 52.94% | 52.76% | 10.11% | Upgrade
|
| Operating Margin | -67.37% | -68.90% | -0.65% | 25.44% | 25.03% | -34.42% | Upgrade
|
| Profit Margin | -68.51% | -67.00% | -1.34% | -18.91% | -373.61% | -11.56% | Upgrade
|
| Free Cash Flow Margin | -34.27% | -55.07% | -0.71% | 10.09% | -33.90% | -3.91% | Upgrade
|
| EBITDA | -12.28 | -12.9 | 0.14 | 16.6 | 22.05 | -28.61 | Upgrade
|
| EBITDA Margin | -51.70% | -53.76% | 0.33% | 26.47% | 45.61% | -25.61% | Upgrade
|
| D&A For EBITDA | 3.72 | 3.64 | 0.42 | 0.64 | 9.95 | 9.85 | Upgrade
|
| EBIT | -16 | -16.54 | -0.28 | 15.96 | 12.1 | -38.46 | Upgrade
|
| EBIT Margin | -67.37% | -68.90% | -0.65% | 25.44% | 25.03% | -34.42% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.